Abstract
The hypoxia-inducible factor (HIF)-1α, which has a major role in cell adaptation to hypoxia, is mainly regulated at post-translational levels. Recently, HIF-1α mRNA was also shown to be upregulated by several signal pathways under normoxic conditions. Here we focused on relationships of HIF-1α with NF-κB and β-catenin signaling in endometrial carcinomas (Em Cas). Long-term exposure of Ishikawa cells to cobalt chloride (CoCl2), which is known to mimic the effect of hypoxia, caused a decrease in the growth, along with increased HIF-1α protein but not mRNA expression. In contrast, short-term exposure resulted in a rapid and transient increase in HIF-1α mRNA expression along with stabilization of nuclear NF-κB/p65 (p65). Transfection of p65 increased HIF-1α expression through activation of the promoter, whereas overexpression of HIF-1α also activated NF-κB-dependent transcription, indicating the existence of a positive feedback loop. In addition, HIF-1α was indirectly associated with nuclear β-catenin through interactions with p300, leading to slight enhancement of both HIF-1α- and β-catenin-mediated transcriptional activity. In clinical samples, biphasic upregulation of HIF-1α expression was observed in normal endometrial glandular components during the menstrual cycle, with the labeling indices showing significantly higher values in the early secretory stage. Significantly higher values for phosphorylated p65 and nuclear β-catenin were also observed in HIF-1α-positive than -negative lesions of Em Cas, in contrast to significantly lower Ki-67 status. These data therefore suggest that transcriptional associations with HIF-1α and NF-κB, as well as β-catenin/p300 complexes, may contribute to modulation of changes in tumor cell kinetics in response to a hypoxic condition in Em Cas.
Similar content being viewed by others
Main
Mammalian cells require a constant supply of oxygen to preserve adequate energy production and to maintain normal function and survival. Cellular hypoxia, characterized by a decreased O2 tension within cells, can be caused by an environmental stress and has important implications in many pathological conditions.1, 2, 3, 4 For example, hypoxia promotes tumor invasion and metastasis through activation of several signaling pathways, such as Ras-extracellular signal-regulated kinase.1 In addition, most hypoxic tumor cells are viable but non-proliferating and resemble a state of tumor dormancy, as described in non-vascularized metastatic foci.2, 3, 4
Hypoxia-inducible factor (HIF)-1 serves as a major transcription factor for the regulation of many genes encoding for metabolic enzymes, growth factors, extracellular matrix, and thrombosis under hypoxic condition.5, 6, 7 In contrast to constitutively expressed HIF-1β, an inducible subunit, HIF-1α, is mainly regulated by oxygen-dependent hydroxylation of two proline residues within the O2-dependent degradation domain. This allows the binding of the von Hipple–Lindue (VHL) tumor suppressor protein, a component of an E3 ubiquitin ligase complex that targets HIF-1α subunits for degradation by the ubiquitin–proteasome pathway.8, 9, 10, 11, 12 Recently, HIF-1α mRNA has also been shown to be upregulated by several signal pathways, including NF-κB.13, 14, 15
In endometrial carcinomas (Em Cas), HIF-1α expression is considered to correlate with a subtype of tumor aggressiveness and activation of the classical NF-κB pathway through nuclear NF-κB/p65 accumulation.16, 17 Moreover, activation of HIF-1α signaling, as well as NF-κB, acts as a key regulator whereby tumor cells adapt to radiation therapy and hypoxia.18 However, little is known about the functional cross-talk between HIF-1α and NF-κB signaling.
β-Catenin is a multifunctional protein involved in E-cadherin-mediated cell–cell adhesion and acts as a downstream effector in the Wnt signaling pathway. Our previous data for Em Cas showed that β-catenin signaling may have an important role in inhibiting cell proliferation through the activation of p14arf/p53/p21waf1, modulating NF-κB pathways.19, 20, 21 Given that G1 cell cycle arrest is induced by an alteration in the Myc-p21waf1 axis under hypoxic condition,22 it is possible that associations among HIF-1α, NF-κB, and β-catenin signaling may have an important role in modulation of tumor kinetics in response to microenvironmental hypoxia in Em Cas. To test this, extensive investigations were conducted on HIF-1α expression, together with examining NF-κB and β-catenin signaling and cell proliferation in Em Cas.
MATERIALS AND METHODS
Plasmids, Cell Lines, Antibodies, and Reagents
Full-length cDNA of human HIF-1α in pCMV-S-Flag vector was obtained from the Riken DNA Bank Human Resource (Tsukuba, Ibaragi, Japan). The human HIF-1α promoter sequence between −625 and +283, as well as the 2075-bp fragment of glucose transporter 1 (Glut1) promoter (NG008232), was amplified by PCR and subcloned into the pGL-3B vector (Promega, Madison, WI, USA), respectively. Site-directed mutagenesis of the putative NF-κB binding sites in the HIF-1α promoter was performed using the PrimeSTAR Mutagenesis Basak kit (Takara Bio, Ohtsu, Japan). In addition, a fragment of the HIF reporter, including HIF-1α regulatory elements (HREs; Qiagen, Tokyo, Japan), was subcloned into the pGL-3B vector. The identities of these constructs were confirmed by sequencing before use. The sequences of PCR primers employed in this study are listed in Table 1. pG5-luc, pcDNA3.1-mouse p65, pcDNA3.1-HA-β-catenin with deleted Serin-45 (β-catΔS45), pCI-Flag-p300, pCI-Flag-p300N, pCI-Flag-p300M, pCI-Flag-p300C, κB-luc, and Top reporters were obtained and used as described previously.19, 20, 21, 23, 24
The endometrial cancer cell lines, Ishikawa, Hec50, and Hec251 cells, as well as Ishikawa cells stably overexpressing HA-β-catΔS45, were maintained in Eagle’s MEM with 10% bovine calf serum.16, 17, 18 For hypoxia experiments, cells were treated with 100 μM cobalt chloride (CoCl2) under 5% CO2 at 37 °C.25, 26, 27
Anti-HIF-1α, anti-p27kip1, anti-VHL, and anti-NF-κB/p65 were from BD Bioscience (San Jose, CA, USA). Anti-cyclin D1, anti-p21waf1, anti-p53, and Ki-67 were from Dako (Copenhagen, Denmark). Anti-phospho-p65 at Ser275 (pp65), anti-phospho-Akt at Ser473 (pAkt), anti-Akt, anti-GSK-3β, anti-phospho-GSK-3β at Ser9 (pGSK-3β), and anti-IκBα were from Cell Signaling (Danvers, MA, USA). Anti-β-actin and anti-Flag were from Sigma Chemical (St Louis, MO, USA), and anti-Glut1 was from Millipore (Billerica, MA, USA). Anti-HA and anti-p300 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Transfection
Transfection was performed using LipofectAMINE PLUS (Invitrogen, Carlsbad, CA, USA), in duplicate or triplicate. Luciferase activity was assayed as described previously.19, 20, 21
Reverse Transcription-PCR
Amplification was performed in the exponential phase (20–28 cycles) to allow comparison among cDNAs synthesized from identical reactions, using specific primers (Table 1). Primers for p21waf1 and GAPDH genes were also applied, as described previously.23, 24
Western Blot Assays
Total cellular proteins were prepared using RIPA buffer (50 mmol/l Tris-HCl (pH7.2), 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS). Nuclear and cytoplasmic fractions were also prepared using NE-PER nuclear and cytoplasmic extraction reagents (Pierce, Rockford, IL, USA). Western blot assays were performed as described previously.19, 20, 21
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation (ChIP) analysis was performed using an EpiXplore ChIP assay kit (Clontech Lab, Mountain View, CA, USA). Briefly, after transient transfection of pcDNA mouse p65, cells were cross-linked with formaldehyde. Cell lysates were sonicated to share DNA to lengths between 200 and 1000 bp, and were then precipitated overnight using anti-NF-κB/p65 antibody or mouse IgG as a negative control, along with magnetic beads. After proteinase K digestion, DNAs were extracted and were analyzed by PCR. ChIP analysis was conducted with a reduction in the number of cycles from 30 to 25, using three specific primer sets.
Immunofluorescence
After cotransfection of pcDNA3.1-HA-β-catΔS45, pCMV-Flag-HIF-1α, or pCI-Flag-p300 into Ishikawa cells, the cells were incubated with primary antibodies to β-catenin, HIF-1α, p300, HA, and Flag. Fluorescein isothiocyanate- or rhodamine-labeled anti-mouse or rabbit IgG (Molecular Probe, Leiden, The Netherlands) were used as secondary antibodies, as described previously.19, 20, 21
Clinical Cases
Histological findings were reviewed for hysterectomy specimens of endometrioid type Em Cas in the case records of the Kitasato University Hospital during the period from 2000 to 2008, according to the criteria of the 2003 World Health Organization classification.28 A total of 64 cases of Em Cas that included 42 of grade (G)1 or 2 and 22 of G3 were investigated. Of G1 tumors, 18 had squamous morules with high levels of nuclear β-catenin accumulation in the surrounding carcinomatous lesions.19, 20, 21 In addition, 40 biopsy specimens of normal endometrial tissues that included 10 in the proliferative, 20 in secretory (10 early and 10 middle and late), and 10 in the menstrual phases were also selected. All tissues were routinely fixed in 10% formalin and processed for embedding in paraffin wax. Approval for this study was provided by the Ethics Committee of the Kitasato University School of Medicine (B07-16).
Immunohistochemistry
Immunohistochemistry (IHC) was performed using a combination of the microwave heating and polymer immunocomplex (Envision, Dako) methods. For the evaluation of immunostaining, tumor lesions were subdivided into HIF-1α-positive and -negative carcinomatous components. Lesions with severe inflammation or necrotic features, probably associated with severe hypoxic effects, were excluded. Nuclei positive for HIF-1α, pp65, β-catenin, and Ki-67 were counted in at least 1000 tumors in each of 5 randomly selected fields for both components in all cases. Labeling indices (LIs) were then calculated as numbers per 100 cells, as described previously.19, 20, 21 HIF-1α-positive carcinomatous lesions were defined when over 20% of cells were stained in each case. Scoring of nuclear immunoreactivity for HIF-1α in normal endometrial samples was also performed on the basis of the percentage of immunoreactive cells and the immunointensity by multiplying values for the two parameters, as described previously.16, 17, 18
In-Situ Hybridization Assays
The HIF-1α cDNA sequence (containing nucleotides 480 to 957; GenBank accession number BC012527) was subcloned into the pCRII vector (Invitrogen) by PCR-based strategy, using a specific primer set as described previously.29 The riboprobes were generated by in vitro transcription using T7 or Sp6 RNA polymerases in the presence of digoxigenin-labeled UTP. In-situ hybridization (ISH) assays were carried out using the GenPoint Tyramide Signal Amplification System (Dako), according to the manufacturer’s instructions.
Statistics
Comparative data were analyzed using the Mann–Whitney U-test. The cut-off value for statistical significance was set as P<0.05.
RESULTS
Relationship Between Hypoxia and Cell Kinetics
The effects of CoCl2 treatment on cell kinetics was examined, because it mimics the effects of hypoxia.25, 26, 27, 30 As shown in Figure 1a, long-term exposure of Ishikawa cells to CoCl2 inhibited growth considerably as compared with controls, along with pronounced increase in HIF-1α protein expression but not mRNA levels. An increased p27kip1 expression was also observed for both mRNA and protein levels but such expressions were relatively minor in cases of p21waf1, and VHL. Hec251 cells showed similar responses to CoCl2 (Supplementary Figure S1A).
Several in vivo studies showed an increase in HIF-1α mRNA levels in mice, rats, and ferrets under hypoxia.31, 32, 33 To determine whether a similar response could be shown in vitro, Ishikawa cells were treated with short-term exposure to CoCl2. As shown in Figure 1b, HIF-1α mRNA levels increased in response to hypoxia within 0.5 hh after CoCl2 treatment, returning to basal levels after 2 h. In contrast, the protein levels rapidly increased within 0.5 h and remained stable for up to 6 h. An increase in nuclear NF-κB/p65 (p65) levels was also observed, peaking at 0.5 to 3 h, along with weak increases in the levels of cytoplasmic IκBα protein. In addition, pretreatment with the transcription inhibitor actinomycin D inhibited CoCl2-mediated HIF-1α expression for both mRNA and protein levels (Figure 1c), strongly suggesting that the regulation occurs at transcriptional levels. Similar findings were also seen in Hec251 cells treated with short-term exposure to hydrogen peroxidase (Supplementary Figure S1B), which can act as a second messenger in the responding to both TNF and okadaic acid stimulation,34 as well as Hec50 cells treated with CoCl2 (Supplementary Figure S1C).
Transcriptional Relationship Between NF-κB/p65 and HIF-1α
Given that basal HIF-1α mRNA levels are controlled by several NF-κB subunits,13, 14, 15 the role of NF-κB/p65 in regulating HIF-1α expression was studied. Transfection of p65 caused an increase in both HIF-1α mRNA and protein expression levels, in line with activation of the promoter, in a dose-dependent manner (Figure 2a).
On the basis of previous data that indicated a consensus binding sequence 5′-GGRNNYYCC-3′,23, 24 we noticed that a 900-bp fragment upstream of the translation start site in the HIF-1α gene was highly GC-rich and contained three potential binding sites for NF-κB (Figure 2b). Additional promoter constructs carrying four nucleotide alterations in the κB-binding sites, including κB1, κB2, and κB3 (Figure 2c), resulted in considerable reduction of response to p65 (Figure 2d). ChIP assays also revealed that transfected p65 recruited the HIF-1α promoter to the three κB-binding sites (Figure 2e), indicating that the three regions are required for the promoter to be stimulated by p65. In contrast, transfection of HIF-1α also exhibited an increase in basal- and p65-meditaed κB-luc reporter activity (Supplementary Figure S2A).
Relationships among HIF-1α, β-catenin, and p300
As the transcriptional activity of stabilized HIF-1α is exerted by recruiting the transcriptional co-activator and integrator p300/CBP,35 the role in HIF-1α-dependent transcription was also examined. As shown in Figure 3a, overexpressing HIF-1α colocalized with the full length of p300 constructs, with a formation of nuclear speckles. Cotransfection with p300N-terminus also resulted in a formation of several enlarged nuclear dots, in contrast to diffuse nuclear/cytoplasmic staining with a few of nuclear aggregates by p300C but not p300M (data not shown). HRE reporter assays exhibited an eightfold increase in activity with a combination of HIF-1α and p300N, whereas such associations were relatively minor in cases of either p300M or p300C (Figure 3b), suggesting that HIF-1α interacts mainly with the N-terminus of p300.
Further studies were performed to determine whether subcellular localization of β-catenin is affected by exposure to hypoxia, as hypoxia is known to alter β-catenin/TCF-dependent transcriptional activity.22, 36 In Ishikawa cells stably overexpressing actively formed β-catenin, treatment with CoCl2 resulted in an increased accumulation of β-catenin in the nuclear but not cytoplasmic fraction, as well as phosphorylated forms of both Akt and GSK-3β (Figure 4a). Colocalization of exogenous β-catenin and HIF-1α was also observed with a few small nuclear aggregates (Figure 4b). Moreover, cotransfection resulted in a slight enhancement of both HRE (HIF-1α)- and Top (β-catenin) reporter activities mediated by either HIF-1α or β-catenin (Figure 4c). Similar enhancement was also observed with the Glut1 promoter (Supplementary Figure S2B), a target gene for HIF-1α.37 In contrast, one hybrid assay revealed little activity of the pG5-luc reporter by cotransfection of the DNA-BD-fused full-length β-catenin fragment (pM-β-cat) and HIF-1α, in contrast to p300N (Figure 4d), indicating that the associations may be indirect.
IHC and ISH Findings in Normal and Malignant Endometrium
Examples of the IHC findings for HIF-1α in the normal endometrium during the menstrual cycle are illustrated in Figure 5a. A distinct nuclear immunoreactivity for HIF-1α was observed generally in epithelial but not stromal components, with the exception of those in menstrual phase. The average IHC scores for HIF-1α were significantly higher in the early secretory than the other menstrual stages.
To examine the relationship of HIF-1α expression with mRNA and protein levels, ISH assays were carried out using 10 Em Ca cases. In carcinoma components without necrotic lesions, positive signals for HIF-1α mRNA appeared to be consistent with high levels of the nuclear immunopositivity in most cases (Figure 5b).
Examples of the IHC findings for HIF-1α, pp65, β-catenin, and Ki-67 are shown in Figure 6a. Immunoreactivity for HIF-1α appeared to overlap with nuclear staining for pp65 and β-catenin but not Ki-67. As shown in Figure 6b, average LI values of HIF-1α, as well as Ki-67, were significantly higher in G3 than G1/2 tumors, in contrast to nuclear β-catenin and pp65. Moreover, significant differences in LIs of pp65, β-catenin, and Ki-67 were observed between HIF-1α-positive and -negative carcinomatous lesions.
DISCUSSION
Evidence has been provided that HIF-1α expression is regulated not only by post-translational modification but also involved transcriptional control by NF-κB/p65, from the following findings. First, short-term treatment of cells with CoCl2 and H2O2 resulted in a rapid and transient increase in HIF-1α mRNA expression, along with stabilization of nuclear p65. At the same time, pretreatment with the transcriptional inhibitor actinomycin D resulted in suppression of the mRNA and protein expression induced by CoCl2 treatment. Second, cells transiently overexpressing p65 exhibited upregulation of HIF-1α mRNA and protein expression through activation of the promoter, in line with the data showing significantly higher pp65 LI values in HIF-1α-positive as compared with HIF-1α-negative components in Em Cas. Third, p65 was capable of binding directly to the three specific regulatory sequences, including nucleotides −377/−368, +149/+158, and +244/+253, within the promoter, as evidenced by inhibition of promoter activity by mutations in the three sequences. In contrast, previous studies demonstrated that activated NF-κB was bound to the putative responsive site at −197/−188 of the promoter in human pulmonary artery smooth muscle cells.13, 38 Other cell type-specific transcriptional factors may also contribute to the promoter-specific mechanism of action.
In contrast to transcriptional upregulation of HIF-1α by NF-κB, overexpression of HIF-1α also caused an increase in NF-κB-mediated transcription, indicating the existence of a positive feedback loop system. This conclusion is supported by our results of high levels of pp65 expression in HIF-1α-positive components of Em Cas. The significantly lower cell proliferation in HIF-1α-positive carcinomatous lesions may be due to the relatively low-oxygenated status, as hypoxia caused cell cycle arrest through a mechanism that was either dependent (p53, p21waf1, and bcl-2) or independent (GADD153) of HIF-1α.39 In fact, long-term treatment of Ishikawa cells with CoCl2 resulted in a significant decrease in growth, leading to upregulation of p27kip1.
A rapidly growing body of evidence indicates that hypoxia triggers a functional switch in β-catenin signaling, as well as PI3K/Akt.22, 35, 40, 41, 42 In this study, CoCl2-meditated hypoxia caused considerable accumulation of nuclear β-catenin, probably due to inactivation of the Akt/GSK-3β-mediated degradation system. This is consistent with the results of significantly higher levels of nuclear β-catenin in HIF-1α-positive lesions of Em Cas. However, the association appeared to be indirect, on the basis of our findings, in one hybrid assay. Given the evidence of a direct association between p300 and either HIF-1α or β-catenin,43 it is likely that the co-activator may be essential for cross-talk between the two signaling components in Em Ca cells.
Another finding of interest in this study was the transient upregulation of HIF-1α expression that was observed in normal endometrial glandular but not stromal components in early secretory stages, despite relatively well-oxygenated tissues. A similar finding was also observed in a case of Sox7, which may be important for changes in cell kinetics from proliferative to secretory stages in the normal endometrium.44 Interestingly, HIF-1α protein has been shown to be upregulated under normoxic condition in response to growth factors, hormones, coagulation factors, cytokines, and vasoactive peptide,45, 46, 47, 48 allowing us to speculate that other factors, in particular estrogen, may serve as positive regulators for HIF-1α expression during the menstrual cycle, independent of O2 tension. In contrast, the relatively higher HIF-1α expression in both glandular and stromal components in menstrual stages may be simply due to hypoxic effects.
Our observations suggest a model for the regulation and function of HIF-1α in Em Ca cells (Figure 7). Activation of the NF-κB pathway due to a variety of stimuli, such as hypoxic condition and several cytokines, causes transactivation of the HIF-1α gene, while HIF-1α can enhance NF-κB-mediated transcriptional activity, through a positive feedback loop system. Overexpression of HIF-1α is also associated indirectly with excess β-catenin, probably due to the gene mutations and hypoxic exposure, by interaction with p300, and this in turn leads to transactivation of their target genes, resulting in tumor adaptation to microenvironmental hypoxia in Em Ca cells.
In conclusion, our results suggest that associations with HIF-1α and the NF-κB pathway, as well as β-catenin/p300 complexes, may participate in modulating changes in tumor kinetics in response to hypoxic stress in Em Cas.
Accession codes
References
Pouyssegur J, Dayan F, Mazure NM . Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 2006;441:437–443.
Durand RE, Raleigh JA . Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res 1998;58:3547–3550.
Webster L, Hodgkiss RJ, Wilson GD . Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo. Br J Cancer 1998;77:227–234.
Barnhill RL, Piekorn MW, Cochran AJ et al. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 1998;134:991–994.
Maxwell PH, Ratcliffe PJ . Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002;13:29–37.
Samoylenko A, Roth U, Jungermann K et al. The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site. Blood 2001;97:2657–2666.
Wenger RH . Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002;16:1151–1162.
Wang GL, Semenza GL . Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270:1230–1237.
Epstein AC, Gleadle JM, McNeill LA et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107:43–54.
Masson N, Willam C, Maxwell PH et al. Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J 2001;20:5197–5206.
Maxwell PH, Wiesener MS, Chang GW et al. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271–275.
Jaakkola P, Mole DR, Tian YM et al. Targeting HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468–472.
BelAiba RS, Bonello S, Zahringer C et al. Hypoxia up-regulates hypoxia-inducible factor-1α transcription by involving phosphatidylinositol 3-kinase and nuclear factor κB in pulmonary artery smooth muscle cells. Mol Biol Cell 2007;18:4691–4697.
Van Uden P, Kenneth NS, Rocha S . Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem J 2008;412:477–484.
Qiao Q, Nozaki Y, Sakoe K et al. NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma. Exp Hematol 2010;38:1199–1208.
Pansare V, Munkarah AR, Schimp V et al. Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas. Mod Pathol 2007;20:35–43.
Yeramian A, Santacana M, Sorolla A et al. Nuclear factor-κB/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner. Lab Invest 2011;91:859–871.
Santacana M, Yeramian A, Velasco A et al. Immunohistochemical features of post-radiation vaginal recurrences of endometrial carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia. Histopathol 2012;60:460–471.
Saegusa M, Hashimura M, Kuwata T et al. β-Catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 2004;164:1739–1749.
Saegusa M, Hashimura M, Kuwata T et al. Crosstalk between NF-κB/p65 and β-catenin/TCF4/p300 signalling pathways through alterations in GSK-3β expression during trans-differentiation of endometrial carcinoma cells. J Pathol 2007;213:35–45.
Saegusa M, Hashimura M, Kuwata T et al. A functional role of Cdx2 in β-catenin signaling during transdifferentiation in endometrial carcinomas. Carcinogenesis 2007;28:1885–1892.
Kaidi A, Williams AC, Paraskeva C . Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007;9:210–217.
Saegusa M, Hashimura M, Kuwata T et al. Requirement of the Akt/β-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of Slug. Am J Pathol 2009;174:2107–2115.
Saegusa M, Hashimura M, Suzuki E et al. Transcriptional up-regulation of sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14ARF/p53/p21WAF1 pathway. Am J Pathol 2012;181:684–692.
Kanaya K, Kamitani T . pVHL-independent ubiquitination of HIF1α and its stabilization by cobalt ion. Biochem Biophys Res Commun 2003;306:750–755.
Yuan Y, Hilliard G, Ferguson T et al. Cobalts inhibit the interaction between hypoxia inducible factor-α and von Hipple-Lindau protein by direct binding to hypoxia inducible factor-α. J Biol Chem 2003;278:15911–15916.
Ardyanto TD, Osaki M, Tokuyasu N et al. CoCl2-induced HIF-1α expression correlates with proliferation and apoptosis in MKN-1 cells: a possible role for the PI3K/Akt pathway. Int J Oncol 2006;29:549–555.
Silverberg SG, Mutter GL, Kurman RJ et al. Tumours of the uterine corpus. Epithelial tumours and related lesions. In: Tavassoli FA, Devilee P (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press: IARC: Lyon, France, 2003, pp 221–232.
Nakanishi K, Hiroi S, Tomonaga S et al. Expression of hypoxia-inducible factor-1α protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin Cancer Res 2005;11:2583–2590.
Salnikow K, Donald SP, Bruick RK et al. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 2004;279:40337–40344.
Wiener CM, Booth G, Semenza GL . In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophhys Res Commun 1996;225:485–488.
Semenza GL, Agani F, Booth G et al. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 1997;51:553–555.
Chen YR, Dai AG, Hu RC et al. Differential and reciprocal regulation between hypoxia-inducible factor-alpha subunits and their prolyl hydroxylases in pulmonary arteries of rat with hypoxia-induced hypertension. Acta Biochem Biophys Sin (Shanghai) 2006;38:423–434.
Schmidt KN, Amstad P, Cerutti P et al. The role of hydrogen peroxide and superoxidate as messengers in the activation of transcription factor NF-κB. Chem Biol 1995;2:13–22.
Gu J, Milligan J, Huang LE . Molecular mechanism of hypoxia-inducible factor 1α-p300 interaction. J Biol Chem 2001;276:3550–3554.
Mazumgar J, O’Brien WT, Johnson RS et al. O2 regulates stem cells through Wnt/β-catenin signaling. Nat Cell Biol 2010;12:1007–1013.
Chen C, Pore N, Behrooz A et al. Regulation of glut1 mRNA by hypoxia-inducible factor-1. J Biol Chem 2001;276:9519–9525.
Bonello S, Zahringer C, BelAiba RS et al. Reactive oxygen species activate the HIF-1α promoter via a functional NF-κB site. Arterioscler Thromb Vasc Biol 2007;27:755–761.
Carmeliet P, Dor Y, Herbert JM et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485–490.
Motte D, Dumont V, Deccache Y et al. Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β pathway in HepG2 cells. J Biol Chem 2003;278:31277–31285.
Giles RH, Lolkema MP, Snijckers CM et al. Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis. Oncogene 2006;25:3065–3070.
Liu L, Zhu X-D, Wang W-Q et al. Activation of β-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 2010;16:2740–2750.
Saegusa M, Hashimura M, Kuwata T et al. Upregulation of TCF4 expression as a transcriptional target of β-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells. Lab Invest 2005;85:768–779.
Saegusa M, Hashimura M, Kuwata T . Sox4 functions as a positive regulator of b-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas. Lab Invest 2012;92:511–521.
Fukuda R, Hirota K, Fan F et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002;277:38205–38211.
Richard DE, Berra E, Pouyssegur J . Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem 2000;275:26765–26771.
Haddad JJ, Land SC . A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α. FEBS Lett 2001;505:269–274.
Kazi AA, Koos RD . Estrogen-induced activation of hypoxia-inducible factor-1a, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinol 2007;148:2363–2374.
Acknowledgements
We thank the Riken DNA Bank Human Resource for their gift of the expression plasmids used in this study. This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (number 23590415).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Laboratory Investigation website
In endometrial carcinoma, hypoxia-inducible factor-1α (HIF-1α) expression correlates with tumor aggressiveness and is a regulator of tumor cell adaption to radiation therapy and hypoxia. This study reveals that transcriptional association of HIF-1α and NF-κB, as well as β-catenin/p300 complexes, may contribute to changes in tumor cell kinetics in response to microenvironmental hypoxia in endometrial carcinoma.
Rights and permissions
About this article
Cite this article
Yoshida, T., Hashimura, M., Mastumoto, T. et al. Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells. Lab Invest 93, 1184–1193 (2013). https://doi.org/10.1038/labinvest.2013.111
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/labinvest.2013.111
Keywords
This article is cited by
-
A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma
Cell Communication and Signaling (2022)
-
Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer
Molecular Cancer (2017)
-
PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis
Journal of Molecular Medicine (2016)
-
Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression
Laboratory Investigation (2015)
-
Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer
Gastric Cancer (2015)